Меню
Набор скоро начнётся NCT05833204

BARBED vs. STANDARD Suture for Colporrhaphy at the End of Laparoscopic Hysterectomy

Без фазы С лечением Vaginal Cuff Complications

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Laparoscopic colporrhaphy with 0-caliber barbed absorbable suture, Laparoscopic colporrhaphy with standard 0-caliber absorbable suture.
Кому может быть актуально
Состояния в реестре: Vaginal Cuff Complications. Базовые параметры: от 18 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Италия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Barbed Versus Standard Suture for Vaginal Cuff Closure After Total Laparoscopic Hysterectomy: a Randomized Controlled Trial

Обзор

Hysterectomy is one of the most common surgical procedures performed worldwide, with more than 400,000 hysterectomies performed annually in the United States. As a consequence, even uncommon complications can affect large numbers of patients. Among potentially life-threatening events, vaginal cuff dehiscence complicates 0.14-1.38% of procedures, and any vaginal cuff complications (dehiscence, hematoma, bleeding, infection) are estimated to affect 4.7-9.8% of patients. In this scenario, any preventive strategy can provide clinically relevant benefits. Regarding colporrhaphy, only the adoption of a laparoscopic approach instead of a vaginal approach is supported by high-quality evidence. Our group demonstrated that the laparoscopic closure of the vaginal cuff after total laparoscopic hysterectomy reduces the incidence of vaginal cuff complications. Among other potentially effective interventions, the use of barbed sutures was associated with a lower incidence of vaginal cuff dehiscence than the standard suture. In a recent meta-analysis, the use of barbed sutures has been associated with a pooled incidence of vaginal cuff dehiscence of 0.4% versus 2% after a traditional vaginal suture. However, this evidence is limited because most pooled studies were retrospective, and only two were randomized controlled trials. Moreover, these two randomized controlled trials had a very small sample size and were not powered to detect clinically relevant differences. On that basis, despite the promising utility of barbed sutures for vaginal cuff closure after total laparoscopic hysterectomy, the choice of the type of suture is not evidence-based but still guided by personal opinions, as well as by the preference and habits of the operators. Therefore, this study aims to investigate whether the laparoscopic vaginal cuff closure with barbed suture determines a lower incidence of vaginal cuff dehiscence and complications than conventional sutures after total laparoscopic hysterectomy.

Вмешательства

  • Процедура Laparoscopic colporrhaphy with 0-caliber barbed absorbable suture
    After the total laparoscopic hysterectomy, the colporrhaphy will be performed using a 0-caliber barbed absorbable suture (V-Loc ™, Covidien, Medtronic)
  • Процедура Laparoscopic colporrhaphy with standard 0-caliber absorbable suture
    After the total laparoscopic hysterectomy, the colporrhaphy will be performed using a 0-caliber absorbable suture made of a coated braided thread (Vicryl; Ethicon Inc, Sommerville, NJ)

Первичные конечные точки

  • Vaginal cuff dehiscence [Срок оценки: 30 days after surgery]
  • Vaginal cuff dehiscence [Срок оценки: 90 days after surgery]
Вторичные конечные точки (8)
  • Vaginal cuff complications [Срок оценки: 30 days after surgery]
  • Vaginal cuff complications [Срок оценки: 90 days after surgery]
  • Hospital stay [Срок оценки: From the date of hospital admission to the date of hospital discharge.]
  • Operative time [Срок оценки: During surgery]
  • Intraoperative blood loss [Срок оценки: During surgery]
  • 30-day post-surgical morbidity [Срок оценки: 30 days after surgery]
  • Quality of life index [Срок оценки: 90 days after surgery]
  • Sexual function [Срок оценки: 90 days after surgery]

Критерии участия

Критерии включения

  • Patients undergoing elective total laparoscopic hysterectomy
  • Surgery performed for the treatment of benign pathology
  • Age > 18 years
  • Surgery performed by laparoscopy
  • Signature of informed consent

Критерии исключения

  • Patients undergoing emergent surgery
  • Patients candidates for hysterectomy for oncological indication
  • Patients who underwent previous radiation therapy
  • Patients allergic to the suture material used in the study
  • Patients unable to express adequate informed consent to participate in the study

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Двойное слепое
Основная цель
Лечение

Центры проведения

Италия · 1 центр
  • AOUI Verona - University of Verona - Department of Obstetrics and Gynecology — Verona

Публикации

  • Uccella S, Zorzato PC, Kho RM. Incidence and Prevention of Vaginal Cuff Dehiscence after Laparoscopic and Robotic Hysterectomy: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2021 Mar;28(3):710-720. doi: 10.1016/j.jmig.2020.12.016. Epub 2021 Jan 5. PMID 33348012
  • Uccella S, Malzoni M, Cromi A, Seracchioli R, Ciravolo G, Fanfani F, Shakir F, Gueli Alletti S, Legge F, Berretta R, Corrado G, Casarella L, Donarini P, Zanello M, Perrone E, Gisone B, Vizza E, Scambia G, Ghezzi F. Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy. Am J Obstet Gynecol. 2018 May;218(5) PMID 29410107

Идентификаторы

NCT: NCT05833204 · BARD

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗